tiprankstipranks
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
Sweden Market
XBRANE
Xbrane Biopharma AB
RESEARCH TOOLSreports

Xbrane Biopharma AB (XBRANE) Income Statement

10 Followers

Xbrane Biopharma AB Income Statement

Last quarter (Q4 2025), Xbrane Biopharma AB's total revenue was kr9.09M, a decrease of -86.21% from the same quarter last year. In Q4, Xbrane Biopharma AB's net income was kr-26.48M. See Xbrane Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 152.35Mkr 198.70Mkr 238.73Mkr 57.62Mkr 11.53M
Gross Profit
kr 74.94Mkr 180.47Mkr 35.39Mkr 41.04Mkr -684.00K
Operating Expenses
kr 106.04Mkr 398.40Mkr 357.55Mkr 210.27Mkr 191.93M
Depreciation and Amortization
kr 14.60Mkr 35.95Mkr 21.43Mkr 16.58Mkr 12.22M
EBITDA
kr -16.50Mkr -181.97Mkr -282.03Mkr -149.34Mkr -167.59M
Operating Income
kr -31.10Mkr -217.92Mkr -310.43Mkr -166.22Mkr -180.40M
Other Income/Expenses
kr -12.83Mkr -35.51Mkr -11.60Mkr -2.30Mkr -2.64M
Pretax Income
kr -43.93Mkr -253.43Mkr -322.03Mkr -168.51Mkr -183.23M
Net Income
kr 127.24Mkr -266.22Mkr -388.17Mkr -172.23Mkr -191.01M
Per Share Metrics
Basic EPS
kr 0.08kr -27.50kr -158.75kr -96.25kr -112.50
Diluted EPS
kr 0.08kr -27.50kr -158.75kr -96.25kr -112.50
Weighted Average Shares Outstanding
 1.52B 9.84M 2.03M 1.80M 1.66M
Weighted Average Shares Outstanding (Diluted)
 1.52B 9.84M 2.03M 1.80M 1.66M
Currency in SEK

Xbrane Biopharma AB Earnings and Revenue History